PhRMA: Biopharmaceutical pipeline looks promising
A report from the Pharmaceutical Research and Manufacturers of America (PhRMA) describes the biopharmaceutical pipeline as "innovative and robust," with a high percentage of possible first-in-class medicines and therapies for diseases with limited treatment options.